
A report by international experts reveals that tainted syrup medicine imported from India caused an outbreak of kidney failure, resulting in the deaths of over 60 children in Gambia last year. The report contradicts Indian authorities' claims that their products were not to blame. While evidence directly links contaminated medicine from Indian drugmaker Maiden Pharmaceuticals Ltd. to 22 deaths, symptoms in 30 other cases were consistent with the effects of the poison. The contaminants, diethylene glycol and ethylene glycol, were identified. Similar cases occurred in Uzbekistan, further raising concerns about the quality of Indian generic medicine. The Indian government has now implemented new regulations requiring government lab testing before exporting cough syrup.
Like
Save
Share